• Phytol: A Design Framework for Mechanistic Assays

  2026-08-17

  Phytol is a multifunctional diterpene that links retinoid X receptor signaling, metabolism, and GABAergic transmission modulation. This article presents an assay-design framework for separating these mechanisms and uses polymer self-assembly research to clarify how experimental architecture affects interpretation.

• Promethazine HCl: From H1 Blockade to Assay Design

  2026-08-17

  Promethazine HCl is more than a histamine antagonist: it is a useful probe for separating receptor-proximal signaling from macrophage ROS and autophagy phenotypes. This guide translates phenothiazine host-directed immunity findings into rigorous assay design, controls, and cross-domain research decisions.

• Polyphyllin H Reverses Paclitaxel Resistance

  2026-08-15

  A 2025 study identifies membrane cholesterol and lipid rafts as actionable regulators of paclitaxel resistance in breast cancer. Polyphyllin H restored drug sensitivity by simultaneously suppressing ABCB1 and ABCC3, providing a mechanistic alternative to single-transporter inhibition.

• DFO for Latent Fingerprint Detection

  2026-08-14

  DFO combines amino-acid reactivity with fluorescence to improve latent print visualization on paper and other porous evidence. This practical guide covers reagent setup, fresh-solution handling, imaging controls, cross-domain assay lessons, and troubleshooting for more reproducible forensic workflows.

• MLN8237 (Alisertib) Research Workflows

  2026-08-14

  Build more informative Aurora A experiments with MLN8237 (Alisertib), from concentration-response and mitotic assays to apoptosis and trained-immunity studies. This workflow connects kinase selectivity with chromatin accessibility, SAM metabolism, and tumor biology while emphasizing controls, exposure design, and troubleshooting.

• Cefoperazone: From MIC to Biliary Models

  2026-08-13

  Cefoperazone sodium salt connects β-lactamase-resistance studies with compartment-aware infection modeling. This article explains how to interpret MIC, MBC, chemical stability, and biliary distribution without confusing in vitro potency with tissue-level efficacy.

• GSK126 Workflow for EZH2 Mechanism Studies

  2026-08-13

  GSK126 enables controlled interrogation of PRC2-dependent gene silencing across cancer epigenetics research, including EZH2-mutant lymphoma and solid-tumor models. This workflow also shows how the compound can be used cautiously to test links between EZH2, autophagy, and neuroinflammation without confusing a research tool result with therapeutic validation.

• JC-1 for Reliable Mitochondrial Assays

  2026-08-12

  JC-1 (SKU A3516) offers a practical ratiometric approach to mitochondrial membrane potential assays, apoptosis detection, and cellular bioenergetics studies. This scenario-based guide explains stock preparation, compatibility, optimization, interpretation, and vendor-selection considerations without treating JC-1 as a standalone measure of cell viability.

• Rocilinostat (ACY-1215): HDAC6 Research Guide

  2026-08-12

  Rocilinostat, also called ACY-1215, is a selective HDAC6 inhibitor with a supplier-reported IC50 of 5 nM. Preclinical multiple myeloma studies associate HDAC6 inhibition with reduced tumor-cell viability, increased apoptosis, and enhanced responses to proteasome inhibitors.

• Lipo3K Transfection Reagent: Practical Workflows

  2026-08-11

  Lipo3K Transfection Reagent supports flexible DNA, siRNA, and mRNA delivery in adherent, suspension, and difficult-to-transfect cells. This practical guide connects low-toxicity transfection with responsive antisense assays, co-transfection design, optimization screens, and troubleshooting decisions.

• DRB for Transcriptional Elongation Studies

  2026-08-11

  Use DRB to dissect RNA polymerase II-dependent transcription, CDK signaling, and the boundary between transcript production and translation. This workflow-focused guide combines dose–time optimization, orthogonal RNA readouts, and practical controls for stem-cell, antiviral, and mechanistic studies.

• a-MSH, amide: A Mechanism-to-Assay Guide

  2026-08-10

  a-MSH, amide is more than a pigmentation stimulus: it is a defined receptor-probing reagent for separating melanocortin signaling from downstream melanin synthesis. This guide translates the αMSH/B16F10 literature into practical assay design, peptide handling, controls, and interpretation for pigmentation and inflammation research.

• EPZ5676: A Mechanism-First DOT1L Assay Guide

  2026-08-09

  EPZ5676 is a highly selective DOT1L inhibitor for connecting SAM-site biochemistry with H3K79 methylation and MLL-rearranged leukemia models. This guide also explains how recent epigenetic immunology research should—and should not—influence assay design.

• Intravesical p21 mRNA-LNP Therapy in Bladder Cancer

  2026-08-08

  The reference study develops chemically modified p21 mRNA encapsulated in lipid nanoparticles for localized intravesical treatment of bladder cancer. Its findings connect restored nuclear p21 expression with cell-cycle suppression, DNA-damage signaling, apoptosis, and reduced tumor growth in an orthotopic mouse model, while also defining a practical framework for evaluating localized mRNA delivery.

• a-MSH, amide: Designing Better Melanogenesis Assays

  2026-08-07

  a-MSH, amide is a defined melanocortin stimulus for mechanistic pigmentation research. This guide shows how to use alpha-melanocyte-stimulating hormone amide to build more interpretable melanogenesis and inflammation assays while avoiding common endpoint and model-selection errors.

16408 records 1/1094 page Next 12345 下5页 Last page